| |
| |
|
| Insider
Information: |
Shandell Jason B. |
| Relationship: |
President and General ... |
| City: |
Rancho Cucamonga |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
179,276 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$7,171,040 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
179,276 |
|
|
| Total
Value |
$7,171,040 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Amphastar Pharmaceuticals, Inc. |
AMPH |
President and General ... |
2020-03-17 |
179,276 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| AMPH |
Amphastar Pharmaceuticals... |
President and General Counsel |
– • – |
2017-05-30 |
4 |
S |
$16.76 |
$131,230 |
D/D |
(7,828) |
241,342 |
0 |
- |
|
| AMPH |
Amphastar Pharmaceuticals... |
President and General Counsel |
– • – |
2017-05-31 |
4 |
S |
$17.26 |
$63,070 |
D/D |
(3,654) |
237,688 |
0 |
- |
|
| AMPH |
Amphastar Pharmaceuticals... |
President and General Counsel |
• • – |
2016-08-22 |
4 |
OE |
$10.46 |
$104,600 |
D/D |
10,000 |
212,961 |
0 |
- |
|
| AMPH |
Amphastar Pharmaceuticals... |
President and General Counsel |
• • – |
2016-09-26 |
4 |
OE |
$10.93 |
$622,966 |
D/D |
56,996 |
259,957 |
0 |
- |
|
| AMPH |
Amphastar Pharmaceuticals... |
President and General Counsel |
• • – |
2016-11-25 |
4 |
OE |
$10.93 |
$22,330 |
D/D |
2,043 |
205,004 |
0 |
- |
|
| AMPH |
Amphastar Pharmaceuticals... |
President and General Counsel |
• • – |
2016-11-28 |
4 |
OE |
$10.93 |
$265,512 |
D/D |
24,292 |
227,253 |
0 |
- |
|
| AMPH |
Amphastar Pharmaceuticals... |
President and General Counsel |
• • – |
2018-03-13 |
4 |
OE |
$11.79 |
$3,537 |
D/D |
300 |
217,248 |
0 |
- |
|
| AMPH |
Amphastar Pharmaceuticals... |
President and General Counsel |
• • – |
2018-03-14 |
4 |
OE |
$11.79 |
$4,716 |
D/D |
400 |
217,348 |
0 |
- |
|
| AMPH |
Amphastar Pharmaceuticals... |
President and General Counsel |
• • – |
2018-11-08 |
4 |
OE |
$10.46 |
$385,711 |
D/D |
36,201 |
235,706 |
0 |
- |
|
| AMPH |
Amphastar Pharmaceuticals... |
President and General Counsel |
• • – |
2018-11-09 |
4 |
OE |
$10.46 |
$168,354 |
D/D |
16,095 |
215,600 |
0 |
- |
|
| AMPH |
Amphastar Pharmaceuticals... |
President and General Counsel |
• • – |
2018-12-03 |
4 |
OE |
$10.48 |
$174,282 |
D/D |
16,630 |
200,445 |
0 |
- |
|
| AMPH |
Amphastar Pharmaceuticals... |
President and General Counsel |
• • – |
2019-02-14 |
4 |
OE |
$15.23 |
$114,514 |
D/D |
7,519 |
175,837 |
0 |
- |
|
| AMPH |
Amphastar Pharmaceuticals... |
President and General Counsel |
• • – |
2019-03-01 |
4 |
OE |
$20.26 |
$151,950 |
D/D |
7,500 |
175,818 |
0 |
- |
|
| AMPH |
Amphastar Pharmaceuticals... |
President and General Counsel |
• • – |
2019-03-15 |
4 |
OE |
$10.93 |
$267,872 |
D/D |
24,508 |
184,998 |
0 |
- |
|
| AMPH |
Amphastar Pharmaceuticals... |
President and General Counsel |
• • – |
2019-05-01 |
4 |
OE |
$10.93 |
$109,300 |
D/D |
10,000 |
169,947 |
0 |
- |
|
| AMPH |
Amphastar Pharmaceuticals... |
President and General Counsel |
• • – |
2020-01-08 |
4 |
OE |
$10.93 |
$273,250 |
D/D |
25,000 |
163,898 |
0 |
- |
|
| AMPH |
Amphastar Pharmaceuticals... |
President and General Counsel |
• • – |
2020-02-05 |
4 |
OE |
$14.40 |
$224,856 |
D/D |
15,615 |
154,513 |
0 |
- |
|
| AMPH |
Amphastar Pharmaceuticals... |
President and General Counsel |
• • – |
2020-02-06 |
4 |
OE |
$14.40 |
$315,835 |
D/D |
21,933 |
160,831 |
0 |
- |
|
| AMPH |
Amphastar Pharmaceuticals... |
President and General Counsel |
• • – |
2020-02-07 |
4 |
OE |
$14.40 |
$98,683 |
D/D |
6,853 |
145,751 |
0 |
- |
|
| AMPH |
Amphastar Pharmaceuticals... |
PresidentOfficer |
• • – |
2014-06-24 |
3/A |
IO |
$0.00 |
$0 |
D/D |
0 |
3,332 |
|
- |
|
| AMPH |
Amphastar Pharmaceuticals... |
PresidentOfficer |
• • – |
2014-06-24 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
127,432 |
|
- |
|
| AMPH |
Amphastar Pharmaceuticals... |
President |
• • – |
2014-07-07 |
4 |
D |
$8.75 |
$38,614 |
D/D |
(4,413) |
123,019 |
0 |
- |
|
| AMPH |
Amphastar Pharmaceuticals... |
President |
• • – |
2014-08-01 |
4 |
D |
$8.84 |
$11,952 |
D/D |
(1,352) |
121,667 |
0 |
- |
|
| AMPH |
Amphastar Pharmaceuticals... |
President |
• • – |
2014-09-26 |
4 |
D |
$11.83 |
$9,109 |
D/D |
(770) |
120,897 |
0 |
- |
|
| AMPH |
Amphastar Pharmaceuticals... |
President |
• • – |
2014-10-03 |
4 |
D |
$11.41 |
$11,273 |
D/D |
(988) |
119,909 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
